Bone Biologics Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bone Biologics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Bone Biologics Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$784K, a 55.7% increase year-over-year.
  • Bone Biologics Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$5.12M, a 11.8% increase year-over-year.
  • Bone Biologics Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$8.95M, a 503% decline from 2022.
  • Bone Biologics Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$1.48M, a 7.83% increase from 2021.
  • Bone Biologics Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$1.61M, a 11.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5.12M -$784K +$986K +55.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$6.1M -$866K +$2.84M +76.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-09
Q4 2023 -$8.95M -$1.55M -$2.44M -273% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$6.51M -$1.92M -$700K -57.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$5.8M -$1.77M -$1.3M -277% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$4.51M -$3.71M -$3.02M -438% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-09
Q4 2022 -$1.48M $893K +$1.07M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 -$2.56M -$1.22M -$710K -139% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$1.85M -$469K +$22.6K +4.59% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$1.87M -$689K -$258K -59.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$1.61M -$178K +$276K +60.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$1.89M -$509K -$115K -29.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.77M -$492K -$112K -29.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$1.66M -$432K +$165K +27.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$1.82M -$454K +$77.4K +14.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$1.9M -$394K +$167K +29.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.07M -$380K +$546K +58.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$2.62M -$597K +$810K +57.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$3.42M -$531K +$940K +63.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$4.36M -$561K -$320K -132% Jul 1, 2019 Sep 30, 2019 10-Q 2021-04-15
Q2 2019 -$4.04M -$926K +$338K +26.7% Apr 1, 2019 Jun 30, 2019 10-Q 2021-04-15
Q1 2019 -$4.38M -$1.41M +$47.9K +3.3% Jan 1, 2019 Mar 31, 2019 10-Q 2021-04-15
Q4 2018 -$4.43M -$1.47M +$1.3M +46.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$5.73M -$242K +$2.13M +89.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$7.86M -$1.26M -$2.28M -224% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$5.58M -$1.45M +$1.47M +50.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$7.05M -$2.77M +$1.93M +41.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$8.98M -$2.38M +$1.84M +43.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$10.8M $1.02M +$5.71M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$16.5M -$2.92M +$9.34M +76.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$25.9M -$4.7M +$3.28M +41.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$29.2M -$4.22M -$858K -25.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-02
Q2 2016 -$28.3M -$4.7M -$3.81M -427% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-02
Q1 2016 -$24.5M -$12.3M -$10.6M -647% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-02
Q4 2015 -$13.9M -$7.98M -$6.92M -653% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$6.96M -$3.36M -$750K -28.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$6.21M -$891K -$463K -108% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$5.74M -$1.64M -$1.32M -407% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$4.42M -$1.06M -$1.06M -53478% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$3.37M -$2.61M -$2.37M -997% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$991K -$428K -$121K -39.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$870K -$324K -$322K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$548K -$1.98K -$361 Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q3 2013 -$548K -$238K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$306K +$782K +71.8% Apr 1, 2013 Jun 30, 2013 8-K 2014-09-25
Q1 2013 -$1.47K* +$677 Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-23
Q4 2012 -$1.62K* -$262 Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q2 2012 -$1.09M -$1.09M May 1, 2012 Jul 31, 2012 10-Q 2013-09-11
Q1 2012 -$2.15K -$948 Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 -$1.36K* -$81 Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q2 2011 -$725* +$6.00 May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 -$1.2K* Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$1.28K* Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 -$731* May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.